摘要:
Methods of, and products for, treating skin with at least two alternating treatment modalities to improve the health and/or diminish signs of aging that comprise topically applying at least two separate compositions, in a sequential, rotating, or alternating fashion to overcome adaptation, tolerance, or sensitization phenomena.
摘要:
Provided are methods of diminishing the signs of aging and/or improving the health of human integuments, such as skin, and compositions useful therefor. The compositions according to the invention comprise a peptide having the sequence AECK (SEQ ID NO: 1) or a derivative thereof, in a topically acceptable vehicle.
摘要翻译:提供了减少老化迹象和/或改善人体皮肤如皮肤健康的方法和用于此的组合物。 根据本发明的组合物在局部可接受的载体中包含具有序列AECK(SEQ ID NO:1)或其衍生物的肽。
摘要:
Provided are methods of diminishing the signs of aging and/or improving the health of human integuments, such as skin, and compositions comprising peptides useful therefor. The compositions according to the invention comprise a peptide comprising the sequence selected from LRLK (SEQ ID NO: 1), MVV (SEQ ID NO: 2), TAKDGAP (SEQ ID NO: 3), IFGGTVYRS (SEQ ID NO: 4), and RTPKISKPIKFELSG (SEQ ID NO: 5) or a derivative, or fragment thereof, in a topically acceptable vehicle.
摘要翻译:提供了减少老化迹象和/或改善人类皮肤如皮肤健康的方法,以及包含对其有用的肽的组合物。 根据本发明的组合物包含含有选自LRLK(SEQ ID NO:1),MVV(SEQ ID NO:2),TAKDGAP(SEQ ID NO:3),IFGGTVYRS(SEQ ID NO:4), 和RTPKISKPIKFELSG(SEQ ID NO:5)或其衍生物或片段在局部可接受的载体中。
摘要:
The invention is generally directed to compositions useful for improving the aesthetic appearance of human skin and the use of those compounds for improving the appearance of human skin, including improving skin tone, reducing the appearance of dark circles under the eyes, and reducing inflammation in the skin. The compositions typically comprise adrenergic receptor agonists.
摘要:
The disclosure relates to novel topical lightening compositions a tyrosinase inhibitor and a vehicle. There is provided a topical lightening composition comprising a 2-substituted-thio-4-substitued-4-oxobutanoic acid, ester or amide tyrosinase inhibitor, and a vehicle. The tyrosinase inhibitors of this disclosure can be used as such or as a pharmaceutically acceptable salt including conventional non-toxic salts which include a metal salt or an alkaline earth metal salt, an ammonium salt, or an organic base salt. The tyrosinase inhibitors of this disclosure can be incorporated into any cosmetically-, dermatologically-, or cosmeticatically- acceptable vehicle or carrier normally used for topical application. The compositions and methods of the disclosure are effective to lighten skin, hair, lips, and/or nails.
摘要:
Cosmetic compositions comprising creatine and low amounts of a biotinylated tripeptide are disclosed, as well as methods of using such compositions to improve the appearance of eyelashes. These compositions are believed to have synergistic modulatory activities in a number of biochemical pathways implicated in lash health.
摘要:
Cosmetic compositions comprising a metal-complexed peptide fraction of stressed yeast extracts and/or a calcium influx inhibitor are disclosed, as well as methods of using such compositions to impart exfoliating, anti-aging, anti-lipid, anti-inflammatory, and/or lightening benefits to the skin; and/or lightening benefits to the hair. These compositions are believed to have modulatory activity against at least one biochemical pathway implicated in skin aging, inflammation, lipid synthesis, and melanin production.
摘要:
Peptides, topical compositions, and methods of improving health and/or appearance of human integuments, such as keratinous surfaces and fibers are provided. The peptides have from 3-12 amino acid residues and comprise the sequence YNT (SEQ ID NO: 1) or PVG (SEQ ID NO: 2).
摘要:
Provided are methods of treating skin with at least two alternating treatment modalities to improve the health and/or diminish signs of aging. Some methods according to the present invention may comprise topically applying at least two separate compositions, in a sequential, rotating, or alternating fashion to overcome adaptation, tolerance, or sensitization phenomena.
摘要:
Embodiments of the invention are generally directed to compositions useful for reducing histamine-induced pigmentation in the skin. The composition may further include other depigmenting agents such as nicotinamide and its melanasome transfer-inhibiting derivatives, 3,3'-thiodipropanoic acid and its tyrosinase-inhibiting derivatives, or resorcinol and its tyrosinase-inhibiting derivatives, in a cosmetically acceptable vehicle.